Alzheimer's disease drug treatment

J. K. Cooper, Dan M Mungas

Research output: Contribution to journalArticle

Abstract

Tacrine may be useful for treating Alzheimer's disease (AD). Its mechanism of action is cholinesterase inhibition, leading to increased brain acetylcholine. Several other AD drugs are in Phase III development. Drugs currently being tested or used for Alzheimer's disease can be grouped into two major categories, those to preserve cognitive function, and those to control abnormal behaviors. Cholinesterase inhibitors belong to the first category, along with drugs to maintain neuron metabolic function, and drugs to reduce neuronal toxins. Drugs to control abnormal behaviors include neuroleptics, anxiolytics, anti-aggression drugs, and serotonin-active drugs. No drugs developed so far have hope of curing AD, but several may be useful in treatment.

Original languageEnglish (US)
Pages (from-to)5-18
Number of pages14
JournalJournal of Geriatric Drug Therapy
Volume8
Issue number2
StatePublished - 1993
Externally publishedYes

Fingerprint

Alzheimer Disease
Pharmaceutical Preparations
Hope
Therapeutics
Serotonin Agents
Tacrine
Behavior Control
Drug and Narcotic Control
Cholinesterase Inhibitors
Cholinesterases
Anti-Anxiety Agents
Aggression
Cognition
Antipsychotic Agents
Acetylcholine
Neurons
Brain

Keywords

  • Alzheimer's disease
  • Anti-aggression drugs
  • Antidepressants
  • Anxiolytics
  • Neuroleptics
  • Nootropics
  • Tacrine

ASJC Scopus subject areas

  • Geriatrics and Gerontology
  • Pharmacology (medical)

Cite this

Alzheimer's disease drug treatment. / Cooper, J. K.; Mungas, Dan M.

In: Journal of Geriatric Drug Therapy, Vol. 8, No. 2, 1993, p. 5-18.

Research output: Contribution to journalArticle

Cooper, J. K. ; Mungas, Dan M. / Alzheimer's disease drug treatment. In: Journal of Geriatric Drug Therapy. 1993 ; Vol. 8, No. 2. pp. 5-18.
@article{59e44b3bc1f74b8fac2fdb99250ff878,
title = "Alzheimer's disease drug treatment",
abstract = "Tacrine may be useful for treating Alzheimer's disease (AD). Its mechanism of action is cholinesterase inhibition, leading to increased brain acetylcholine. Several other AD drugs are in Phase III development. Drugs currently being tested or used for Alzheimer's disease can be grouped into two major categories, those to preserve cognitive function, and those to control abnormal behaviors. Cholinesterase inhibitors belong to the first category, along with drugs to maintain neuron metabolic function, and drugs to reduce neuronal toxins. Drugs to control abnormal behaviors include neuroleptics, anxiolytics, anti-aggression drugs, and serotonin-active drugs. No drugs developed so far have hope of curing AD, but several may be useful in treatment.",
keywords = "Alzheimer's disease, Anti-aggression drugs, Antidepressants, Anxiolytics, Neuroleptics, Nootropics, Tacrine",
author = "Cooper, {J. K.} and Mungas, {Dan M}",
year = "1993",
language = "English (US)",
volume = "8",
pages = "5--18",
journal = "Journal of Geriatric Drug Therapy",
issn = "8756-4629",
publisher = "Haworth Press Inc.",
number = "2",

}

TY - JOUR

T1 - Alzheimer's disease drug treatment

AU - Cooper, J. K.

AU - Mungas, Dan M

PY - 1993

Y1 - 1993

N2 - Tacrine may be useful for treating Alzheimer's disease (AD). Its mechanism of action is cholinesterase inhibition, leading to increased brain acetylcholine. Several other AD drugs are in Phase III development. Drugs currently being tested or used for Alzheimer's disease can be grouped into two major categories, those to preserve cognitive function, and those to control abnormal behaviors. Cholinesterase inhibitors belong to the first category, along with drugs to maintain neuron metabolic function, and drugs to reduce neuronal toxins. Drugs to control abnormal behaviors include neuroleptics, anxiolytics, anti-aggression drugs, and serotonin-active drugs. No drugs developed so far have hope of curing AD, but several may be useful in treatment.

AB - Tacrine may be useful for treating Alzheimer's disease (AD). Its mechanism of action is cholinesterase inhibition, leading to increased brain acetylcholine. Several other AD drugs are in Phase III development. Drugs currently being tested or used for Alzheimer's disease can be grouped into two major categories, those to preserve cognitive function, and those to control abnormal behaviors. Cholinesterase inhibitors belong to the first category, along with drugs to maintain neuron metabolic function, and drugs to reduce neuronal toxins. Drugs to control abnormal behaviors include neuroleptics, anxiolytics, anti-aggression drugs, and serotonin-active drugs. No drugs developed so far have hope of curing AD, but several may be useful in treatment.

KW - Alzheimer's disease

KW - Anti-aggression drugs

KW - Antidepressants

KW - Anxiolytics

KW - Neuroleptics

KW - Nootropics

KW - Tacrine

UR - http://www.scopus.com/inward/record.url?scp=0027893036&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027893036&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0027893036

VL - 8

SP - 5

EP - 18

JO - Journal of Geriatric Drug Therapy

JF - Journal of Geriatric Drug Therapy

SN - 8756-4629

IS - 2

ER -